Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NOVOLIN 70/30 safely and effectively. See full prescribing information for NOVOLIN 70/30. NOVOLIN® 70/30 (insulin isophane human and insulin human) injectable suspension, for subcutaneous use Initial U.S. Approval: 1991
Medication labelWhy this: Advisory · dailymed-otc
NOVOLIN 70/30 is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Limitations of Use: In NOVOLIN 70/30, the proportions of short-acting and intermediate-acting insulins are fixed and do not allow for basal versus prandial dose adjustments.
- generic_name
- human insulin
- product_names
- Human Insulin
- ndc
- 50090-0403, 0169-1837, 50090-0403-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en